Heterologous protection elicited by a live, attenuated, Leptospira vaccine
- PMID: 30173751
- DOI: 10.1016/j.vetmic.2018.07.018
Heterologous protection elicited by a live, attenuated, Leptospira vaccine
Abstract
A previously-described live, attenuated vaccine (M1352, serovar Manilae, serogroup Pyrogenes) was tested in the hamster model of infection for cross-protective immunity. The vaccine elicited strong, significant cross-protection against lethal infection by strains representing four serologically distinct leptospiral serovars (Grippotyphosa, Australis, Canicola, and Autumnalis). Combined with our previously reported protection against serovars Pomona and Manilae, this work demonstrates unequivocal proof of concept for cross-protective immunity in leptospirosis.
Keywords: Cross-protection; Leptospirosis; Live vaccine; Serovar.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant.J Infect Dis. 2011 Mar 15;203(6):870-9. doi: 10.1093/infdis/jiq127. Epub 2011 Jan 10. J Infect Dis. 2011. PMID: 21220775 Free PMC article.
-
Identification of in vivo expressed proteins in live attenuated lipopolysaccharide mutant that mediates heterologous protection against Leptospira spp.Vet Microbiol. 2021 Nov;262:109220. doi: 10.1016/j.vetmic.2021.109220. Epub 2021 Aug 30. Vet Microbiol. 2021. PMID: 34509026
-
A canine vaccine against Leptospira serovars Icterohaemorrhagiae, Canicola and Grippotyphosa provides cross protection against Leptospira serovar Copenhageni.Vet Immunol Immunopathol. 2020 Jan;219:109985. doi: 10.1016/j.vetimm.2019.109985. Epub 2019 Nov 15. Vet Immunol Immunopathol. 2020. PMID: 31759261
-
Expansion of the in vitro assay for Leptospira potency testing to other serovars: case study with Leptospira Hardjo.Biologicals. 2013 Sep;41(5):323-4. doi: 10.1016/j.biologicals.2013.06.003. Epub 2013 Jul 6. Biologicals. 2013. PMID: 23838569 Review.
-
Vaccines against leptospirosis.Curr Top Microbiol Immunol. 2015;387:251-72. doi: 10.1007/978-3-662-45059-8_10. Curr Top Microbiol Immunol. 2015. PMID: 25388138 Review.
Cited by
-
Leptospira borgpetersenii Leucine-Rich Repeat Proteins Provide Strong Protective Efficacy as Novel Leptospiral Vaccine Candidates.Trop Med Infect Dis. 2022 Dec 22;8(1):6. doi: 10.3390/tropicalmed8010006. Trop Med Infect Dis. 2022. PMID: 36668913 Free PMC article.
-
Challenges for the development of a universal vaccine against leptospirosis revealed by the evaluation of 22 vaccine candidates.Front Cell Infect Microbiol. 2022 Oct 7;12:940966. doi: 10.3389/fcimb.2022.940966. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36275031 Free PMC article.
-
Vaccination With Leptospira interrogans PF07598 Gene Family-Encoded Virulence Modifying Proteins Protects Mice From Severe Leptospirosis and Reduces Bacterial Load in the Liver and Kidney.Front Cell Infect Microbiol. 2022 Jun 28;12:926994. doi: 10.3389/fcimb.2022.926994. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35837473 Free PMC article.
-
Pathogenic Leptospires Limit Dendritic Cell Activation Through Avoidance of TLR4 and TRIF Signaling.Front Immunol. 2022 Jun 22;13:911778. doi: 10.3389/fimmu.2022.911778. eCollection 2022. Front Immunol. 2022. PMID: 35812397 Free PMC article.
-
Revisiting the Development of Vaccines Against Pathogenic Leptospira: Innovative Approaches, Present Challenges, and Future Perspectives.Front Immunol. 2022 Jan 3;12:760291. doi: 10.3389/fimmu.2021.760291. eCollection 2021. Front Immunol. 2022. PMID: 35046936 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
